Marksans Pharma standalone net profit declines 20.73% in the December 2017 quarter

Sales rise 23.92% to Rs 80.03 crore

Net profit of Marksans Pharma declined 20.73% to Rs 5.62 crore in the quarter ended December 2017 as against Rs 7.09 crore during the previous quarter ended December 2016. Sales rose 23.92% to Rs 80.03 crore in the quarter ended December 2017 as against Rs 64.58 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales80.0364.58 24 OPM %14.3821.04 -PBDT10.2512.48 -18 PBT7.668.72 -12 NP5.627.09 -21

Powered by Capital Market - Live News